- Home
- HBIO vs LSTA Comparison
HBIO vs LSTA Comparison
Compare HBIO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- LSTA
- Stock Information
- Founded
- HBIO 1901
- LSTA 1980
- Country
- HBIO United States
- LSTA United States
- Employees
- HBIO N/A
- LSTA N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- LSTA Misc Health and Biotechnology Services
- Sector
- HBIO Industrials
- LSTA Health Care
- Exchange
- HBIO Nasdaq
- LSTA Nasdaq
- Market Cap
- HBIO 16.9M
- LSTA 20.0M
- IPO Year
- HBIO 2000
- LSTA N/A
- Fundamental
- Price
- HBIO $0.40
- LSTA $2.39
- Analyst Decision
- HBIO Buy
- LSTA Strong Buy
- Analyst Count
- HBIO 2
- LSTA 1
- Target Price
- HBIO $4.50
- LSTA $15.00
- AVG Volume (30 Days)
- HBIO 349.2K
- LSTA 13.3K
- Earning Date
- HBIO 05-06-2025
- LSTA 05-08-2025
- Dividend Yield
- HBIO N/A
- LSTA N/A
- EPS Growth
- HBIO N/A
- LSTA N/A
- EPS
- HBIO N/A
- LSTA N/A
- Revenue
- HBIO $94,135,000.00
- LSTA $1,000,000.00
- Revenue This Year
- HBIO N/A
- LSTA N/A
- Revenue Next Year
- HBIO $8.58
- LSTA N/A
- P/E Ratio
- HBIO N/A
- LSTA N/A
- Revenue Growth
- HBIO N/A
- LSTA N/A
- 52 Week Low
- HBIO $0.36
- LSTA $1.87
- 52 Week High
- HBIO $4.08
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- HBIO 35.65
- LSTA 60.67
- Support Level
- HBIO $0.56
- LSTA $1.91
- Resistance Level
- HBIO $0.45
- LSTA $2.09
- Average True Range (ATR)
- HBIO 0.06
- LSTA 0.18
- MACD
- HBIO 0.02
- LSTA 0.06
- Stochastic Oscillator
- HBIO 28.71
- LSTA 100.00
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.